B+
Bull case
0%
Probability
Target price
$235.00
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
UFPT
UFPDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
UFPT remains a differentiated medtech CDMO with about 92% of revenue tied to MedTech, 26 of the top 30 medical OEMs as customers, and visible capacity/program expansion in robotic surgery and safe patient handling; if 2026 ramps convert into better organic growth and margin recovery, the current price can look too low versus the packet’s median target data point.
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-03.
What can break
CEO transition on June 4, 2026 could create short-term uncertainty even with planned continuity.
Momentum
69
Value
55
Sentiment
30
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $198.00 · Bull $235.00 · Bear $160.00Analysis 2026-04-15; returns require an exact persisted reference.
Earnings
2026-11-03
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-11-02 • Vendor: Data Vendor v1
Scores
As of 2026-10-30 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-30
Investment thesis
As of 2026-10-30
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-30. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $355.00
Why
Momentum69 · Δ7d +6.5
Value55 · Δ7d +0.7
Sentiment30 · Δ7d +4.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-03.
- • Value remains the lead driver in the composite, 7D delta +0.7.
Contradictions & invalidation
- • CEO transition on June 4, 2026 could create short-term uncertainty even with planned continuity.
- • Customer concentration, including dependence on the largest customer and contract volume assumptions [#10-K-2026-02-27].
- • The company still carries meaningful customer concentration, recent growth leaned heavily on acquisitions, 2025 organic growth was only about 1.5%, and execution issues at AJR plus leadership transition risk make it hard to underwrite a clean re-acceleration today [#10-K-2026-02-27].
Catalyst clock
2026-11-03
Q1 2026 print must confirm that 2025 execution drags are fading
Lead driver: Value · See fundamentals
Momentum
69
8% active weight
Current posture
7d trendImproving
Δ7d
+6.5
Δ21d
+8.1
Value
55
47% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
+0.3
Sentiment
30
45% active weight
Current posture
7d trendImproving
Δ7d
+4.7
Δ21d
+0.4
Why this grade
Composite grade D. Momentum 68.6 / Value 54.9 / Sentiment 29.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-15. Scenario method
Most likely
B
Base case
1%
Probability
Target price
$198.00
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$160.00
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-11-02
Fundamentals (TTM)
As of 2026-11-02
Market Cap
$2.2B
Beta
1.10
Shares Out
7.75M
P/E (TTM)
27.6
P/S (TTM)
3.06
P/FCF (TTM)
20.93
Rev YoY
+15.1%
EPS YoY
+21.1%
Gross Margin
+28.5%
Op Margin
+15.2%
Net Debt
$134.18M
Current Ratio
3.00
As of 2026-10-30 • Updated nightlySource: Internal modelMethods & Data